Jessica Chan, PA-C

Jessica Chan practices at Christopher F Amsden Medical Corporation in Modesto, California.

Jessica Chan's NPI, 1164992277, was assigned on December 1, 2018. Jessica Chan holds California license 55993.

Jessica Chan's primary practice is Christopher F Amsden Medical Corporation, at 1524 Mc Henry Ave, Modesto, CA 95350 in Stanislaus County. The practice phone is (209) 525-8292.

Jessica Chan's primary practice is Christopher F Amsden Medical Corporation in Modesto, California. Jessica Chan is also affiliated with Memorial Medical Center. The medical group on file is Vituity. Dmand AI also links Jessica Chan to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Jessica Chan practices, 2 sites in all. Vendor and product names are available with a free account.

Physician assistant is Jessica Chan's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Jessica Chan is licensed in California.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, facial skin infection, itchy rashes, minor injury to a limb and psoriasis among the conditions Jessica Chan treats.

CMS data shows 7,318 Medicare services from Jessica Chan across 20 procedure codes in 2024, for 917 Medicare patients. Medicare paid $289,182 for them. Every service was in an office.

CMS counts 917 Medicare patients who saw Jessica Chan in 2024. The largest group is 65 to 74, with 443 patients. 75% of them have high cholesterol, and 69% have high blood pressure. 6% are also on Medicaid. Their average risk score is 0.89, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Jessica Chan's median patient age at 71, with 61% women.

In 2024, Jessica Chan wrote 1,320 Medicare Part D claims for 526 patients. 94% of them were for generic drugs. CMS names the drug for 1,242 of them, across 18 drugs with 11 or more claims each, at $481,883 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Jessica Chan for performance year 2024, reported individually. Jessica Chan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 79 general payments to Jessica Chan from 18 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 88% of the total. Janssen Pharmaceuticals, Inc paid the most, $983.